Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Rotigotine in RLS Extension
NCT00498186Phase 2Completed
- Sponsor
- UCB
- Start
- Jul 2003
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started Jul 2003; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00498186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498186.